228 related articles for article (PubMed ID: 25820525)
1. Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension.
Helenius MH; Vattulainen S; Orcholski M; Aho J; Komulainen A; Taimen P; Wang L; de Jesus Perez VA; Koskenvuo JW; Alastalo TP
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1046-57. PubMed ID: 25820525
[TBL] [Abstract][Full Text] [Related]
2. Purinergic dysregulation in pulmonary hypertension.
Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
[TBL] [Abstract][Full Text] [Related]
3. CD39 AS A CRITICAL ECTONUCLEOTIDASE DEFENSE AGAINST PATHOLOGICAL VASCULAR REMODELING.
Pinsky DJ
Trans Am Clin Climatol Assoc; 2018; 129():132-139. PubMed ID: 30166707
[TBL] [Abstract][Full Text] [Related]
4. Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.
Aliagas E; Muñoz-Esquerre M; Cuevas E; Careta O; Huertas D; López-Sánchez M; Escobar I; Dorca J; Santos S
Respir Res; 2018 May; 19(1):103. PubMed ID: 29807526
[TBL] [Abstract][Full Text] [Related]
5. Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension.
Visovatti SH; Hyman MC; Bouis D; Neubig R; McLaughlin VV; Pinsky DJ
PLoS One; 2012; 7(7):e40829. PubMed ID: 22792409
[TBL] [Abstract][Full Text] [Related]
6. Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertension.
Roy C; Tabiasco J; Caillon A; Delneste Y; Merot J; Favre J; Guihot AL; Martin L; Nascimento DC; Ryffel B; Robson SC; Sévigny J; Henrion D; Kauffenstein G
Purinergic Signal; 2018 Mar; 14(1):73-82. PubMed ID: 29236227
[TBL] [Abstract][Full Text] [Related]
7. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells.
Imai M; Kaczmarek E; Koziak K; Sévigny J; Goepfert C; Guckelberger O; Csizmadia E; Schulte Am Esch J; Robson SC
Biochemistry; 1999 Oct; 38(41):13473-9. PubMed ID: 10521254
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
9. Deletion of cd39/entpd1 results in hepatic insulin resistance.
Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
[TBL] [Abstract][Full Text] [Related]
10. NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow.
Favre J; Roy C; Guihot AL; Drouin A; Laprise M; Gillis MA; Robson SC; Thorin E; Sévigny J; Henrion D; Kauffenstein G
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894719
[TBL] [Abstract][Full Text] [Related]
11. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
12. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.
Beldi G; Wu Y; Sun X; Imai M; Enjyoji K; Csizmadia E; Candinas D; Erb L; Robson SC
Gastroenterology; 2008 Nov; 135(5):1751-60. PubMed ID: 18804472
[TBL] [Abstract][Full Text] [Related]
13. Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis.
Kanthi Y; Hyman MC; Liao H; Baek AE; Visovatti SH; Sutton NR; Goonewardena SN; Neral MK; Jo H; Pinsky DJ
J Clin Invest; 2015 Aug; 125(8):3027-36. PubMed ID: 26121751
[TBL] [Abstract][Full Text] [Related]
14. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
15. The P2-receptor-mediated Ca
Hennigs JK; Lüneburg N; Stage A; Schmitz M; Körbelin J; Harbaum L; Matuszcak C; Mienert J; Bokemeyer C; Böger RH; Kiefmann R; Klose H
Purinergic Signal; 2019 Sep; 15(3):299-311. PubMed ID: 31396838
[TBL] [Abstract][Full Text] [Related]
16. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
17. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
[TBL] [Abstract][Full Text] [Related]
18. The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons.
Corti F; Olson KE; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2011 May; 337(2):524-32. PubMed ID: 21325440
[TBL] [Abstract][Full Text] [Related]
19. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
[TBL] [Abstract][Full Text] [Related]
20. Decreased ecto-NTPDase1/CD39 activity leads to desensitization of P2 purinoceptors regulating tonus of corpora cavernosa in impotent men with endothelial dysfunction.
Faria M; Magalhães-Cardoso T; Lafuente-de-Carvalho JM; Correia-de Sá P
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):761-8. PubMed ID: 18600538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
